Groupe Francophone Des Myelodysplasies

This study is testing whether adding an existing drug (ESA) to a newer drug (luspatercept) works better than luspatercept alone for patients with a lower-risk type of MDS, a bone marrow disorder that causes anemia. The trial is for adults whose anemia did not improve or got worse…

This study is testing whether the drug momelotinib can help control symptoms in adults with VEXAS syndrome, a rare and serious inflammatory condition. Participants will take the drug daily along with their current steroid medication to see if it reduces disease symptoms and allow…